Jeff Bezos’ Startup Prometheus Secures $12 Billion for AI Tools in Physical Product and Drug Development

• June 13, 2026

Jeff Bezos, the founder of Amazon, has unveiled significant developments surrounding his new artificial intelligence startup, Prometheus. The company recently attracted $12 billion in funding to advance its work on innovative AI-powered software designed to transform the creation of physical products and pharmaceuticals.

Developing the ‘Artificial General Engineer’ for Product Innovation

Prometheus is focusing on building a software platform named the “Artificial General Engineer” (AGE). This AI-driven system aims to assist in the comprehensive design, testing, and manufacturing processes of tangible goods. The goal is to streamline and enhance how new products, including medicines, are developed by leveraging advanced artificial intelligence technologies.

By deploying AGE, Prometheus envisions improving efficiency and accuracy in engineering workflows, potentially reducing time and costs commonly associated with bringing physical innovations to market. The startup’s approach integrates various stages from conceptualizing prototypes to conducting simulations and overseeing production aspects through intelligent automation.

Although technical specifications and detailed operational capabilities of the AGE platform have yet to be fully disclosed, the substantial capital raised underscores investor confidence in Prometheus’ mission and technological direction. The funding positions the company as a notable competitor among emerging AI ventures focused on engineering and manufacturing sectors.

The application of such AI systems extends across numerous industries where physical product design and drug formulation are critical. By harnessing artificial intelligence at this scale, Prometheus aims to disrupt traditional processes, driving a new wave of innovation within product development and pharmaceutical research.

Details regarding the deployment timeline or potential partnerships have not been revealed at this stage. However, the commitment to developing artificial general engineering tools highlights a growing trend of integrating AI more deeply into tasks historically reliant on human expertise.

Prometheus thrives under the leadership of Bezos, who has transitioned from e-commerce and space exploration to championing advancements in artificial intelligence technology. The fresh influx of funding marks a significant milestone early in the company’s lifecycle, potentially signaling impactful changes ahead in how products and drugs are conceived and manufactured globally.

Jeff Bezos’ new startup Prometheus raised $12 billion to develop AI software for designing and producing physical products and medicines.